Head and Neck or Liver Cancer: Testing New Drug Combinations

We are studying whether combinations of BI 765063, ezabenlimab, chemotherapy, cetuximab, and BI 836880 can help people with head and neck or liver cancer. This research aims to find more effective treatment options.

What diseases are being studied?

Health conditions and diseases that the clinical trial is designed to study and treat.

Where is the clinical trial being conducted?

Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.

Loading map...
Institut Curie
Département Oncologie Médicale
Paris, France
Oncopole Claudius Regaud
IUCT-O
Portet-sur-Garonne, France
Centr Georges Francois Leclerc
Oncologie Médicale
Saint-Apollinaire, France

Sponsor: Boehringer Ingelheim International GmbH
Last updated: Nov 26, 2025

Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.